Acepodia Biotech, Inc.
4 clinical trials · Sponsor
◉ Watch Acepodia Biotech, Inc.
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease (NCT07061938) | Acepodia Biotech, Inc. | 2026-01-01 |
| ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR) (NCT06415487) | Acepodia Biotech, Inc. | 2024-08-22 |
| ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies (NCT05653271) | Acepodia Biotech, Inc. | 2023-01-21 |
| ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors (NCT04319757) | Acepodia Biotech, Inc. | 2020-06-24 |
Track Acepodia Biotech, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.